Professor, Surgery, Mayo Medical School
General Surgery
Dr. Barbara A. Pockaj, MD
|
|
Give Review
Doctor Barbara A. Pockaj, MD works in the field of General Surgery. He studied medicine at Vanderbilt University School of Medicine. He received 7 awards: "America's Top Doctors", "Top Doctors:Arizona State", "America's Top Doctors for Cancer", "Redbook Magazine: Top Breast Cancer Doctors", "Top MD", "Super Doctor" and "Fellow (FACS)". Doctor Barbara A. Pockaj, MD is a published doctor as well. He has 98 publications published. The latest was: Folate Receptor- (FOLR1) Expression and Function in Triple Negative Tumors. Barbara Pockaj is registered with Medicare and accepts Medicare payments.
Publications
- Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma is Associated with a Low Risk of Same-Nodal-Basin Recurrences.
- Perioperative patient-reported outcomes predict serious postoperative complications: a secondary analysis of the COST trial.
- Importance of lymph node involvement in pancreatic neuroendocrine Tumors: impact on survival and implications for surgical resection.
- Staging Studies for Cutaneous Melanoma in the United States: A Population-Based Analysis.
- Thoracoscopy for Internal Mammary Node Dissection of Metastatic Breast Cancer.
- Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection?
- Surgeon bias in sentinel lymph node dissection: Do Tumor characteristics influence decision making?
- ExCellent local control with preoperative radiation therapy, surgical resection, and intra-operative electron radiation therapy for retroperitoneal sarcoma.
- Nodal Counts and Lymph Node Ratio Impact Survival After Distal Pancreatectomy for Pancreatic AdenoCarcinoma.
- Impact of Breast Reconstruction on the Decision to Undergo Contralateral Prophylactic Mastectomy.
- Validation study of a modern treatment algorithm for nipple discharge.
- Papillary lesions on core Breast biopsy: excisional biopsy for all patients?
- Six-year Outcome of a Prospective Study Evaluating Tumor Bed Boost with Intra-operative Electron Irradiation Followed by whole-Breast Irradiation for Early-Stage Breas...
- Neoadjuvant therapy and Breast cancer surgery: a closer look at postoperative complications.
- Preoperative imaging for early-stage cutaneous melanoma: predictors, usage, and utility at a single institution.
- Is postexcision, preradiation mammogram necessary in patients after Breast-conserving surgery with negative margins.
- Androgen Receptor-Positive Triple Negative Breast Cancer: A Unique Breast Cancer Subtype.
- Limitations of Lymph Node Ratio, Evidence-Based Benchmarks, and the Importance of a Thorough Lymph Node Dissection in Melanoma.
- Integration of radiation oncology with surgery as combined-modality treatment.
- Compliance with guidelines in the surgical management of cutaneous melanoma across the USA.
- Current Use and Surgical Efficacy of Laparoscopic Colectomy in Colon Cancer.
- Effect of body mass index on Tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831.
- Preservation of the deep muscular fascia and locoregional control in melanoma.
- Metastatic carcinoid Tumors-are we making the cut?
- Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.
- Etiology of Breast masses after autologous Breast reconstruction.
- Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma: A North Central Cancer Treatment Group Study, N0675.
- Deep clonal profiling of formalin fixed paraffin embedded clinical samples.
- Atypical Ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?
- The changing landscape of axillary surgery: Which Breast cancer patients may still benefit from complete axillary lymph node dissection?
- A Phase II Trial of Docetaxel and Carboplatin Administered Every 2 Weeks as Preoperative Therapy for Stage II or III Breast Cancer: NCCTG Study N0338.
- Clinical and self Breast examination remain important in the era of modern screening.
- Underuse of curative surgery for early stage upper gastrointestinal Cancers in the United States.
- The Impact of Obesity on Breast Cancer: A Retrospective Review.
- Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841.
- Influence of uncommon histology on Breast conservation therapy for Breast cancer-biology dictates technique?
- The impact of biopsy technique on upstaging, residual Disease, and outcome in cutaneous melanoma.
- Validation of the Updated 7th Edition AJCC TNM Staging Criteria for Gastric AdenoCarcinoma.
- Radioactive seed localization for nonpalpable Breast lesions: review of 1,000 consecutive procedures at a single institution.
- Malignant Peripheral Nerve Sheath Tumors (MPNST): The Mayo Clinic Experience.
- Preoperative predictors of nipple-areola complex involvement for patients undergoing mastectomy for Breast cancer.
- Mayo clinic consensus recommendations for the depth of excision in primary cutaneous melanoma.
- Can lymphatic drainage of head and neck melanoma be predicted?
- Long-Term Follow-Up and Individual Item Analysis of Quality of Life Assessments Related to Laparoscopic-Assisted Colectomy in the COST Trial 93-46-53 (INT 0146).
- Desmoplastic melanoma - the step-child in the melanoma family?
- Risk factors associated with local and in-transit Recurrence of cutaneous melanoma.
- Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral Breast cancer.
- Early results from a novel quality outcomes program: the American Society Of Breast Surgeons' Mastery of Breast Surgery.
- Use of preoperative magnetic resonance imaging for invasive lobular Cancer: good, better, but maybe not the best?
- Triple-negative Breast cancers: unique clinical presentations and outcomes.
- Metastasectomy and surgical resection of the primary tumor in patients with stage IV Breast cancer: time for a second look?
- Outpatient surgery performed in an ambulatory surgery center versus a hospital: comparison of perioperative time intervals.
- Safety and efficacy of perforator flap Breast reconstruction with combined intraabdominal procedures.
- Is excisional biopsy indicated for patients with lobular neoplasia diagnosed on percutaneous core needle biopsy of the Breast?
- Scientific Presentation Award: The impact of magnetic resonance imaging on surgical treatment of invasive Breast cancer.
- Does magnetic resonance imaging accurately predict residual disease in Breast cancer?
- Quality of life after Breast cancer surgery: What have we learned and where should we go next?
- Advantages of preoperative computed tomography in deep inferior epigastric artery perforator flap Breast reconstruction.
- Localized gastric or gastroesophageal Cancer - chemoradiation is a pertinent component of adjuvant treatment for patients at high risk of relapse.
- Factors influencing time between biopsy and definitive surgery for malignant melanoma: do they impact clinical outcome?
- Applications of SPECT/CT in nuclear radiology.
- Desmoplastic melanoma: true positive and false negative findings on F-18 FDG-PET/CT.
- Can surgeons improve survival in stage IV melanoma?
- A multi-site validation trial of radioactive seed localization as an alternative to wire localization.
- Statement of the science concerning locoregional treatments after preoperative chemotherapy for Breast cancer: a National Cancer Institute conference.
- The optimal management of the axillae of patients with microinvasive Breast cancer in the sentinel lymph node era.
- Navigating murky waters: a modern treatment algorithm for nipple discharge.
- Laparoscopic mesh repair of transverse rectus abdominus muscle and deep inferior epigastric flap harvest site hernias.
- Breast cancer presenting as unilateral arm edema.
- Optimal management and challenges in treatment of upper facial melanoma.
- Diagnosis and treatment of malignant melanoma of the foot.
- Cyclooxygenase-2 inhibitor enhances the efficacy of a Breast cancer vaccine: role of IDO.
- Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
- DIEP and pedicled TRAM flaps: a comparison of outcomes.
- Older age independently predicts a lower risk of sentinel lymph node metastasis in Breast cancer.
- Breast cancer: presentation and intervention in women with gastrointestinal metastasis and carcinomatosis.
- Breast cancer-related lymphedema.
- Is Breast cancer sentinel lymph node mapping valuable for patients in their seventies and beyond?
- The potential of 5-hydryoxytryptophan for hot flash reDuction: a hypothesis.
- The deep inferior epigastric perforator flap for Breast reconstruction in overweight and obese patients.
- Sentinel lymph node metastases detected by immunohistochemistry only do not mandate complete axillary lymph node dissection in Breast cancer.
- Injection of (99m)Tc-labeled sulfur colloid the day before operation for Breast cancer sentinel lymph node mapping is as successful as injection the day of operation.
- Radioactive seed localization of nonpalpable Breast lesions is better than wire localization.
- A concordance study of subareolar and subdermal injections for Breast cancer sentinel lymph node mapping.
- Diaphragm Disease after use of nonsteroidal anti-inflammatory agents: first report of diagnosis with capsule endoscopy.
- Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant Breast augmentation.
- Acute and chronic results of adjuvant radiotherapy after mastectomy and Transverse Rectus Abdominis Myocutaneous (TRAM) flap reconstruction for Breast cancer.
- Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with Breast cancer.
- Pilot evaluation of mirtazapine for the treatment of hot flashes.
- Pilot evaluation of black cohosh for the treatment of hot flashes in women.
- Changing surgical therapy for melanoma of the external ear.
- Reoperation on the abdomen encased in adhesions.
- Locally invasive cutaneous Apophysomyces elegans infection acquired from snapdragon patch test.
- Sentinel lymph node biopsy demonstrating concomitant melanoma and mantle Cell lymphoma.
- An update on adjuvant interferon for melanoma.
- Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors.
- ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative Breast cancer.
Schools
Vanderbilt University School Of Medicine
Case Western Res University
Nih National Cancer Institute
Procedures Preformed
- Abdominal Mass Biopsy
- Adjacent Tissue Transfer
- Appendectomy, Laparoscopic
- Biopsy of Breast
- View All
Conditions Treated
- Actinic Keratosis
- Anemia
- Angiosarcoma of the Breast
- Appendicitis
- View All
Doctors Specialties
- Breast Surgical Oncology
- Dermatologic Oncology
- General Surgery
- Oncoplastic Surgery
- Surgical Oncology
Accepted Insurances
- Assurant Health
- Blue Card PPO
- Great West Healthcare-Cigna PPO
- Golden Rule
- GEHA
- Humana
- MultiPlan PPO
- Choice Plus POS
- Options PPO
Awards
- America's Top Doctors
- Top Doctors:Arizona State
- America's Top Doctors for Cancer
- Redbook Magazine: Top Breast Cancer Doctors
- Top MD
- Super Doctor
- Fellow (FACS)
Education
-
Case Western Reserve University - University Hospitals -
Vanderbilt University School of Medicine
Hospital
-
Mayo Clinic - Phoenix/Scottsdale, Arizona
Drug Facts
| NPI NUMBER | 1982689402 | |
| NPPES Provider LastName | POCKAJ | |
| NPPES Provider FirstName | BARBARA | |
| NPPES Provider ZIPCode | 850544502 | |
| NPPES Provider State | AZ | |
| Specialty Description | General Surgery | |
| Total Claim Count | 14.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982689402 |
| Last Name Of The Provider | POCKAJ |
| First Name Of The Provider | BARBARA |
| View All |
